Exhibit 10.2
NUVATION BIO INC.
STOCK OPTION GRANT NOTICE
2021 EQUITY INCENTIVE PLAN—LONG-TERM INCENTIVE PROGRAM
Nuvation Bio Inc. (the “Company”), pursuant to its 2021 Equity Incentive Plan (as amended and/or restated as of the Date of Grant set forth below, the “Plan”), has granted to Optionholder an option to purchase the number of shares of the Common Stock set forth below (the “Option”). The Option is subject to all of the terms and conditions as set forth herein and in the Plan, the Stock Option Agreement, and the Notice of Exercise, all of which are attached hereto and incorporated herein in their entirety. Capitalized terms not explicitly defined herein but defined in the Plan or the Stock Option Agreement shall have the meanings set forth in the Plan or the Stock Option Agreement, as applicable. If the Company uses an electronic capitalization table system (such as Carta or Equity Edge/E*Trade) and the fields below are blank or the information is otherwise provided in a different format electronically, the blank fields and other information (such as exercise schedule and type of grant) shall be deemed to come from the electronic capitalization system and is considered part of this Grant Notice.
Optionholder: |
|
Date of Grant: |
|
Vesting Commencement Date: |
|
Number of Shares Subject to Option: |
|
Exercise Price (Per Share): |
|
Total Exercise Price: |
|
Expiration Date: |
|
Exercise Schedule: |
|
Type of Grant: |
|
Vesting Schedule and Allocation of the Number of Shares Subject to Option:
Payment: By one or a combination of the following items (described in the Option Agreement):
Optionholder Acknowledgements: By Optionholder’s signature below or by electronic acceptance or authentication in a form authorized by the Company, Optionholder understands and agrees that the Option is governed by this Stock Option Grant Notice, and the provisions of the Plan and the Stock Option Agreement and the Notice of Exercise, all of which are made a part of this document. By accepting this Option, Optionholder consents to receive this Grant Notice, the Stock Option Agreement, the Plan, and any other Plan-related documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company. Optionholder represents that he or she has read and is familiar with the provisions of the Plan and the Stock Option Agreement. Optionholder acknowledges and agrees that this Grant Notice and the Stock Option Agreement (together, the “Option Agreement”) may not be modified, amended or revised except in a writing signed by Optionholder and a duly authorized officer of the Company. Optionholder further acknowledges that in the event of any conflict between the provisions in this Grant Notice, the Option Agreement, the Notice of Exercise and the terms of the Plan, the terms of the Plan shall control. Optionholder further acknowledges that the Option Agreement sets forth the entire understanding between Optionholder and the Company regarding the acquisition of Common Stock and supersedes all prior oral and written agreements, promises and/or representations on that subject with the exception of other equity awards previously granted to Optionholder and any written employment agreement, offer letter, severance agreement, written severance plan or policy, or other written agreement between the Company and Optionholder in each case that specifies the terms that should govern this Option. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and any counterpart so delivered will be deemed to have been duly and validly delivered and be valid and effective for all purposes.
Nuvation Bio Inc. |
| Optionholder:
| ||
By: |
|
| By: |
|
| (Signature) |
|
| (Signature) |
Title: |
|
| Email: |
|
Date: |
|
| Date: |
|
NUVATION BIO INC.
2021 Equity Incentive Plan—Long-Term Incentive Program
OPTION AGREEMENT
(INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION)
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, Nuvation Bio Inc. (the “Company”) has granted you an option under its 2021 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. The option is granted to you effective as of the date of grant set forth in the Grant Notice (the “Date of Grant”). If there is any conflict between the terms in this Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.
The details of your option, in addition to those set forth in the Grant Notice and the Plan, are as follows:
1.
267996812 v1
2.
267996812 v1
If your option is an Incentive Stock Option, note that to obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the Date of Grant and ending on the day three months before the date of your option’s exercise, you must be an employee of the Company or an Affiliate, except in the event of your death or Disability. The Company has provided for extended exercisability of your option under certain circumstances for your benefit but cannot guarantee that your option will necessarily be treated as an Incentive Stock Option if you continue to provide services to the Company or an Affiliate as a Consultant or Director after your employment terminates or if you otherwise exercise your option more than three months after the date your employment with the Company or an Affiliate terminates.
3.
267996812 v1
4.
267996812 v1
5.
267996812 v1
6.
267996812 v1
7.
267996812 v1
8.
267996812 v1
EXHIBIT A
VESTING SCHEDULE
The Option granted pursuant to your Grant Notice and subject to the Option Agreement will vest conditioned on the satisfaction of two separate vesting requirements before the Expiration Date (or earlier termination of your Option pursuant to the Option Agreement or the Plan): A time and service based requirement (“Time and Service Based Requirement”) and a milestone based requirement (“Milestone Requirement”), each as described below. Tranche 1 Performance-Based Options, Tranche 2 Performance-Based Options, and Tranche 3 Performance-Based Options will each have their own respective Time and Service Based Requirement and Milestone Requirement.
[_________________________]
267996812 v1